417
Views
8
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Left Ventricular Diastolic Dysfunction in COPD May Manifest Myocardial Ischemia

, , , , , , , , , , , & show all
Pages 305-309 | Received 10 Jan 2012, Accepted 20 Jan 2012, Published online: 09 May 2012

References

  • Dario-Vizza C., J.P. Lynch, L.L. Ochoa, Right and Left Ventricular dysfunction in patients with severe pulmonary disease. Chest 1998; 113: 576–83.
  • Boussuges A, Pinet C, and Molenat F, Left atrial and ventricular filling in COPD. An echocardiographic and Doppler study. Am J Respir Crit Care Med 2000 Aug; 162(2Pt 1): 670–5.
  • Bhattacharyya P, Roy Chowdhury S, Nag S, Sarkar D, Ghosh G, Bardhan S, Banerjee A, Basu A. Diastolic dysfunction in advanced COPD patients: Early results of an observational study. Respirology 2004; 9:A98.
  • Bardhan S, Sarkar D, Nag S, Prevalence of diastolic dysfunction in COPD patients of a pulmonary OPD. Paper submitted in NAPCON, Kolkata, 2005.
  • Funk GC, Lang I, Schenk P, Valpour A, Hartl S, Burghuber OC. Left Ventricular Diastolic Dysfunction in patients with COPD inthe presence and absence of elevated pulmonary arterial pressure. Chest 2008; 133:1354–9.
  • Bhattacharyya P, Roy Chowdhury S, Ghosh Acharyya D. Nag S, Sarkar D. Prevalence and risk factors of left ventricular diastolic dysfunction in COPD patients. Chest Poster Presentations 2005; 128(4):263S.
  • Bhattacharyya P, Acharyya D, Nag S, Bardhan S, Ghosh M, Dey R, Roy S, De N, Sharma RK, Sharma SK. Left ventricular diastolic dysfunction in COPD without any risk factor may have association with myocardial ischemia; Oral presentation in European Respiratory Congress, Vienna, Austria, Sep-12-16, 2009, [Abstract No:4467].
  • Celli BR, MacNee W, Agusti A, Anzueto A, Berg B, Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23:932–46.
  • Rabe KF, Hurd S, Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Updated consensus guidelines for the diagnosis, management and prevention of COPD. Am J Respir Crit Care Med 2007; 176: 532–55.
  • NIH. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure—NIH report, August 2004. [http://www.nhlbi.nih.gov].
  • Position statement of ADA: Diagnosis and classification of Diabetes Mellitus, Diabetes Care 2011; 34(suppl): S62–S69.
  • Nagaya N, Satoh T, Uematsu M, Shortening of Doppler-derived deceleration time of early diastolic transmitral flow in the presence of pulmonary hyper tension through ventricular interaction. Am J Cardiol 1997; 79(11):1502–6.
  • Song GJ, Oldershow PJ. Left ventricular dysfunction in obstructive lung disease: an echo- cardio graphic and angiographic study of cor pulmonale patients with decreased mitral E-F slope. Int J Cardiol 1989; 25:47–53.
  • Cargill RI, Kiely DG, Lipworth BJ. Adverse effects of hypoxaemia on diastolic filling in humans. Clin Sci (Lond) 1995; 89(2): 165–9.
  • Hirono O, Kubota I, Minamihaba O, Fatema K, Kato S, Nakamura H, Tomoike H. Left ventricular diastolic dysfunction in patients with bronchial asthma with long- term oral beta2-adrenoceptor agonists. Am J 2001 Dec; 142(6):E11.
  • Stone AC, Nici L. Other systemic manifestations of COPD. Rochester CL, Guest Editor, Clinics in Chest Medicine, COPD 2007; 28(3):555.
  • Bhattacharyya P. COPD, CRP and coronary artery disease. Chest (India Edition) Editorials 2005; 6(2):63.
  • Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular disease? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003; 107:1514–9.
  • Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia- initiated angiogenesis. Nature 1992; 359:843–5.
  • Zvezdin B, Milutinov S, Koijicic M, A post-mortem analysis of major causes early death in patients hospitalized with chronic obstructive pulmonary disease. Chest 2009; 136:376–80.
  • Ervin F. End-of-life care in chronic obstructive pulmonary disease. BCMJ 2008; 50(3):155–7.
  • Anthonisen, NR, Connett, JE, Enright, PL, Hospitalizations and mortality in the Lung Health Study. Am J Respir Crit Care Med 2002; 166:333–9.
  • Sidney S, Sorel M, Quesenberry CP Jr, COPD and incident cardiovascular diease hospitalizations and mortality. Kaiser Permanente Medical Care Program. Chest 2005; 128:2068–75.
  • Sin DD. Is COPD really a cardiovascular disease? Chest 2009; 136:329–30.
  • Gibbons RJ, Abrams J, Chatterjee K, ACC/AHA guidelines update for the management of patients of chronic stable angina: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, 2002. (www.acc.org/clinical/guidelines/stable/stable.pdf).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.